Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 224 of 1,261
  1. US 11512066

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  2. US 11512060

    1,2,4-oxadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  3. US 11511001

    Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  4. US 11510998

    Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria, cobalamin C type, and deficiency of MMACHC

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  5. US 11510984

    Anhydrous sodium thiosulfate and formulations thereof

    Fennec Pharmaceuticals, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  6. US 11510916

    Pharmaceutical compositions for intraocular administration and methods for fabricating thereof

    EYE CARE NORTHWEST, PA · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  7. US 11510872

    Nanoparticle-lipid composite carriers and uses thereof

    Northwestern University · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  8. US 11510904

    Methods of treating malignant lymphoproliferative disorders

    ACTUATE THERAPEUTICS INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  9. US 11510996

    Covalent polymer-antigen conjugated particles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  10. US 11510927

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  11. US 11512052

    Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  12. US 11512141

    Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment

    The Board of Regents of the University of Texas System · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  13. US 11510887

    Sobetirome in the treatment of myelination diseases

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  14. US 11512078

    Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition

    SuZhou Connect Biopharmaceuticals, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  15. US 2022370646

    PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS

    BRACCO IMAGING SPA [IT] · Granted Nov 24, 2022 · Expires Nov 19, 2042

    granted
  16. CA 3217490

    MASITINIB POUR LE TRAITEMENT DU CANCER DE LA PROSTATE RESISTANT A LA CASTRATION

    AB SCIENCE [FR] · Granted Nov 24, 2022 · Expires Nov 19, 2042

    granted
  17. US 11504389

    Tau modulators and methods and compositions for delivery thereof

    Sangamo Therapeutics, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  18. US 11505593

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  19. US 11505798

    Methods and compositions for treating inflammatory diseases

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  20. US 11505790

    Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  21. US 11504325

    Micelles and vesicles for the delivery of glycopeptides

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  22. US 11505574

    Modulation of P53 for the treatment of cancer

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  23. US 11505782

    Cell-based vehicles for potentiation of viral therapy

    Calidi Biotherapeutics, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  24. US 11505601

    Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum

    Nanjing Legend Biotech Co., Ltd · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.